Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 11 |
GO:0043226 | organelle | 2 | 11 |
GO:0043228 | non-membrane-bounded organelle | 3 | 11 |
GO:0043229 | intracellular organelle | 3 | 11 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0030684 | preribosome | 3 | 1 |
GO:0030687 | preribosome, large subunit precursor | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0034399 | nuclear periphery | 2 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Related structures:
AlphaFold database: A4HMK3
Term | Name | Level | Count |
---|---|---|---|
GO:0009987 | cellular process | 1 | 11 |
GO:0022613 | ribonucleoprotein complex biogenesis | 4 | 11 |
GO:0042254 | ribosome biogenesis | 5 | 10 |
GO:0044085 | cellular component biogenesis | 3 | 11 |
GO:0071840 | cellular component organization or biogenesis | 2 | 11 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006364 | rRNA processing | 8 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016072 | rRNA metabolic process | 7 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0042273 | ribosomal large subunit biogenesis | 5 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 47 | 51 | PF00656 | 0.639 |
CLV_NRD_NRD_1 | 16 | 18 | PF00675 | 0.465 |
CLV_NRD_NRD_1 | 185 | 187 | PF00675 | 0.239 |
CLV_NRD_NRD_1 | 220 | 222 | PF00675 | 0.257 |
CLV_NRD_NRD_1 | 224 | 226 | PF00675 | 0.232 |
CLV_NRD_NRD_1 | 270 | 272 | PF00675 | 0.517 |
CLV_NRD_NRD_1 | 8 | 10 | PF00675 | 0.453 |
CLV_PCSK_FUR_1 | 221 | 225 | PF00082 | 0.235 |
CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.450 |
CLV_PCSK_KEX2_1 | 121 | 123 | PF00082 | 0.239 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.239 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.474 |
CLV_PCSK_KEX2_1 | 185 | 187 | PF00082 | 0.239 |
CLV_PCSK_KEX2_1 | 210 | 212 | PF00082 | 0.281 |
CLV_PCSK_KEX2_1 | 223 | 225 | PF00082 | 0.251 |
CLV_PCSK_KEX2_1 | 244 | 246 | PF00082 | 0.372 |
CLV_PCSK_KEX2_1 | 263 | 265 | PF00082 | 0.246 |
CLV_PCSK_KEX2_1 | 270 | 272 | PF00082 | 0.552 |
CLV_PCSK_KEX2_1 | 70 | 72 | PF00082 | 0.479 |
CLV_PCSK_PC1ET2_1 | 10 | 12 | PF00082 | 0.450 |
CLV_PCSK_PC1ET2_1 | 121 | 123 | PF00082 | 0.239 |
CLV_PCSK_PC1ET2_1 | 149 | 151 | PF00082 | 0.257 |
CLV_PCSK_PC1ET2_1 | 210 | 212 | PF00082 | 0.239 |
CLV_PCSK_PC1ET2_1 | 223 | 225 | PF00082 | 0.239 |
CLV_PCSK_PC1ET2_1 | 244 | 246 | PF00082 | 0.301 |
CLV_PCSK_PC1ET2_1 | 263 | 265 | PF00082 | 0.259 |
CLV_PCSK_PC1ET2_1 | 70 | 72 | PF00082 | 0.479 |
CLV_PCSK_PC7_1 | 206 | 212 | PF00082 | 0.239 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.267 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.505 |
CLV_PCSK_SKI1_1 | 186 | 190 | PF00082 | 0.285 |
CLV_PCSK_SKI1_1 | 241 | 245 | PF00082 | 0.372 |
CLV_Separin_Metazoa | 201 | 205 | PF03568 | 0.239 |
DEG_SPOP_SBC_1 | 103 | 107 | PF00917 | 0.257 |
DOC_CKS1_1 | 249 | 254 | PF01111 | 0.372 |
DOC_PP1_RVXF_1 | 87 | 93 | PF00149 | 0.372 |
DOC_PP4_FxxP_1 | 92 | 95 | PF00568 | 0.239 |
DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.241 |
DOC_USP7_MATH_1 | 63 | 67 | PF00917 | 0.710 |
DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.568 |
DOC_USP7_UBL2_3 | 189 | 193 | PF12436 | 0.239 |
DOC_USP7_UBL2_3 | 263 | 267 | PF12436 | 0.317 |
DOC_WW_Pin1_4 | 248 | 253 | PF00397 | 0.352 |
LIG_14-3-3_CanoR_1 | 101 | 111 | PF00244 | 0.252 |
LIG_14-3-3_CanoR_1 | 136 | 141 | PF00244 | 0.282 |
LIG_14-3-3_CanoR_1 | 185 | 189 | PF00244 | 0.392 |
LIG_FHA_1 | 105 | 111 | PF00498 | 0.257 |
LIG_FHA_2 | 185 | 191 | PF00498 | 0.317 |
LIG_FHA_2 | 86 | 92 | PF00498 | 0.336 |
LIG_LIR_Apic_2 | 91 | 95 | PF02991 | 0.259 |
LIG_LIR_Gen_1 | 152 | 163 | PF02991 | 0.290 |
LIG_NRP_CendR_1 | 270 | 273 | PF00754 | 0.607 |
LIG_PCNA_yPIPBox_3 | 121 | 135 | PF02747 | 0.205 |
LIG_PCNA_yPIPBox_3 | 221 | 234 | PF02747 | 0.301 |
LIG_SH2_NCK_1 | 4 | 8 | PF00017 | 0.474 |
LIG_SH2_SRC | 4 | 7 | PF00017 | 0.571 |
LIG_SH2_SRC | 48 | 51 | PF00017 | 0.596 |
LIG_SH2_STAP1 | 155 | 159 | PF00017 | 0.251 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.596 |
LIG_SUMO_SIM_anti_2 | 130 | 136 | PF11976 | 0.257 |
LIG_TRAF2_1 | 51 | 54 | PF00917 | 0.744 |
MOD_CDK_SPK_2 | 248 | 253 | PF00069 | 0.317 |
MOD_CDK_SPxxK_3 | 248 | 255 | PF00069 | 0.317 |
MOD_CK1_1 | 106 | 112 | PF00069 | 0.260 |
MOD_CK1_1 | 66 | 72 | PF00069 | 0.679 |
MOD_CK2_1 | 136 | 142 | PF00069 | 0.257 |
MOD_CK2_1 | 184 | 190 | PF00069 | 0.341 |
MOD_CK2_1 | 232 | 238 | PF00069 | 0.193 |
MOD_CK2_1 | 29 | 35 | PF00069 | 0.687 |
MOD_CK2_1 | 48 | 54 | PF00069 | 0.477 |
MOD_CK2_1 | 85 | 91 | PF00069 | 0.313 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.500 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.455 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.284 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.542 |
MOD_N-GLC_1 | 226 | 231 | PF02516 | 0.439 |
MOD_NEK2_1 | 102 | 107 | PF00069 | 0.239 |
MOD_NEK2_1 | 172 | 177 | PF00069 | 0.282 |
MOD_NEK2_1 | 213 | 218 | PF00069 | 0.372 |
MOD_PIKK_1 | 29 | 35 | PF00454 | 0.591 |
MOD_PKA_2 | 184 | 190 | PF00069 | 0.372 |
MOD_Plk_2-3 | 232 | 238 | PF00069 | 0.165 |
MOD_Plk_4 | 127 | 133 | PF00069 | 0.260 |
MOD_ProDKin_1 | 248 | 254 | PF00069 | 0.352 |
MOD_SUMO_for_1 | 120 | 123 | PF00179 | 0.239 |
MOD_SUMO_rev_2 | 236 | 246 | PF00179 | 0.294 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.251 |
TRG_ER_diArg_1 | 15 | 17 | PF00400 | 0.598 |
TRG_ER_diArg_1 | 203 | 206 | PF00400 | 0.269 |
TRG_ER_diArg_1 | 252 | 255 | PF00400 | 0.372 |
TRG_ER_diArg_1 | 270 | 273 | PF00400 | 0.576 |
TRG_NLS_Bipartite_1 | 210 | 227 | PF00514 | 0.239 |
TRG_NLS_MonoCore_2 | 220 | 225 | PF00514 | 0.241 |
TRG_NLS_MonoCore_2 | 8 | 13 | PF00514 | 0.432 |
TRG_NLS_MonoExtC_3 | 220 | 225 | PF00514 | 0.261 |
TRG_NLS_MonoExtN_4 | 221 | 227 | PF00514 | 0.239 |
TRG_NLS_MonoExtN_4 | 241 | 248 | PF00514 | 0.301 |
TRG_NLS_MonoExtN_4 | 9 | 14 | PF00514 | 0.435 |
TRG_Pf-PMV_PEXEL_1 | 108 | 113 | PF00026 | 0.317 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I326 | Leptomonas seymouri | 71% | 100% |
A0A0S4IQU9 | Bodo saltans | 58% | 100% |
A0A1X0P5U9 | Trypanosomatidae | 74% | 100% |
A0A3Q8IPE1 | Leishmania donovani | 88% | 100% |
A0A3R7KIH6 | Trypanosoma rangeli | 68% | 100% |
A4IB82 | Leishmania infantum | 88% | 100% |
C9ZZK7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E9AF03 | Leishmania major | 86% | 100% |
E9B659 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
Q09958 | Caenorhabditis elegans | 30% | 80% |
Q9D903 | Mus musculus | 31% | 89% |